• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , May 28

ENTREPRENEURIAL companies doing high-end research in bio-technology can look forward to tapping research infrastructure being set up in the Capital.

The Institute of Genomics and Integrative Biology (IGIB) has partnered with the US-based investment entity, The Chatterjee Group (TCG), to set up genomic application research facility at Okha, New Delhi.

The Centre for Genomic Application's research and development facility will be used as a shared resource for all research centres in the country, according to a communication issued here.

Set up through a 50:50 financial participation between IGIB, an institute under the Council for Scientific and Industrial Research (CSIR) and TCG, through its Institute of Molecular Medicine - the facility has an estimated project cost of Rs 25 crore.

This investment would be shared between TCG, the Department of Science and Technology and CSIR.

The technical and research support will also be provided by CSIR and DST.

More Stories on : Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Political turmoil, stock markets may dent May auto sales

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line